Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Genet Med ; 20(5): 480-485, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29121006

RESUMEN

PurposeNoninvasive prenatal screening (NIPS) using cell-free DNA in maternal blood is highly sensitive for detecting fetal trisomies 21, 18, and 13. Using a genome-wide approach, other chromosome anomalies can also be detected. We report on the origin, frequency, and clinical significance of these other chromosome aberrations found in pregnancies at risk for trisomy 21, 18, or 13.MethodsWhole-genome shallow massively parallel sequencing was used and all autosomes were analyzed.ResultsIn 78 of 2,527 cases (3.1%) NIPS was indicative of trisomy 21, 18, or 13, and in 41 (1.6%) of other chromosome aberrations. The latter were of fetal (n = 10), placental (n = 22), maternal (n = 1) or unknown (n = 7). One case lacked cytogenetic follow-up. Nine of the 10 fetal cases were associated with an abnormal phenotype. Thirteen of the 22 (59%) placental aberrations were associated with fetal congenital anomalies and/or poor fetal growth (

Asunto(s)
Aberraciones Cromosómicas , Trastornos de los Cromosomas/diagnóstico , Trastornos de los Cromosomas/genética , Pruebas Genéticas , Diagnóstico Prenatal , Trisomía , Variaciones en el Número de Copia de ADN , Femenino , Pruebas Genéticas/métodos , Genómica/métodos , Humanos , Placenta/metabolismo , Embarazo , Resultado del Embarazo , Diagnóstico Prenatal/métodos , Secuenciación Completa del Genoma
2.
J Genet Couns ; 26(6): 1348-1356, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28667567

RESUMEN

Increasingly, high-risk pregnant women opt for non-invasive prenatal testing (NIPT) instead of invasive diagnostic testing. Since NIPT is less accurate than invasive testing, a normal NIPT result might leave women less reassured. A questionnaire study was performed among pregnant women with elevated risk for fetal aneuploidy based on first-trimester combined test (risk ≥1:200) or medical history, who were offered NIPT in the nationwide Dutch TRIDENT study. Pre- and post-test questionnaires (n = 682) included measures on: experiences with NIPT procedure, feelings of reassurance, anxiety (State-Trait Anxiety Inventory, STAI), child-related anxiety (PRAQ-R), and satisfaction. The majority (96.1%) were glad to have been offered NIPT. Most (68.5%) perceived the waiting time for NIPT results (mean: 15 days, range 5-32) as (much) too long. Most women with a normal NIPT result felt reassured (80.9%) or somewhat reassured (15.7%). Levels of anxiety and child-related anxiety were significantly lower after receiving a normal NIPT result as compared to the moment of intake (p < 0.001). Women with inadequate health literacy or a medical history (e.g. previous child with trisomy) experienced significantly higher post-test-result anxiety (Mean (M) STAI = 31.6 and 30.0, respectively) compared to those with adequate health literacy (M = 28.6) and no medical history (M = 28.6), indicating these women might benefit from extra information and/or guidance when communicating NIPT test-results. Introducing NIPT as an alternative to invasive testing, led to an offer that satisfied and largely reassured high-risk pregnant women.


Asunto(s)
Aceptación de la Atención de Salud/psicología , Satisfacción Personal , Diagnóstico Prenatal/psicología , Adulto , Ansiedad/psicología , Síndrome de Down/diagnóstico , Femenino , Alfabetización en Salud , Humanos , Embarazo , Primer Trimestre del Embarazo/psicología , Diagnóstico Prenatal/métodos , Encuestas y Cuestionarios
3.
Prenat Diagn ; 36(3): 216-23, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26774010

RESUMEN

OBJECTIVE: To validate Illumina's two-channel NextSeq 500 sequencing system for noninvasive prenatal testing (NIPT) of fetal whole chromosome and partial aberrations. METHODS: A total of 162 plasma samples, previously sequenced for NIPT on a SOLiD 5500xl platform, were sequenced on the NextSeq 500 using 75-bp single-end sequencing, followed by analysis using the WISECONDOR algorithm. RESULTS: For whole chromosome aneuploidy detection, all samples were classified correctly (in total 3× T13, 3× T18, 8× T21 and 145× euploid). Three partial aberrations (36-Mb terminal loss of 5p, 14-Mb gain on 18p and 33-Mb terminal loss of 13q) were also correctly identified. Fetal fractions in 34 male samples sequenced on both the SOLiD 5500xl and NextSeq 500 platform showed no significant difference. To test robustness, two sample sets, containing both euploid and aneuploid samples, were sequenced on different NextSeq 500 machines, revealing identical results. With unchanged laboratory flow, the NIPT turnaround time could be reduced from 15-16 calendar days to 7-8 calendar days, after switching from the SOLiD 5500xl to the NextSeq 500 platform. CONCLUSIONS: The NextSeq 500 platform can be used for NIPT to detect both whole and partial chromosome aberrations. It has fast turnaround times and is suitable for mid-sized laboratories.


Asunto(s)
Aberraciones Cromosómicas , Trastornos de los Cromosomas/diagnóstico , Pruebas Genéticas/métodos , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Diagnóstico Prenatal/métodos , Líquido Amniótico/química , Líquido Amniótico/metabolismo , Vellosidades Coriónicas/química , Vellosidades Coriónicas/metabolismo , ADN/análisis , ADN/sangre , Femenino , Feto/metabolismo , Humanos , Masculino , Embarazo
4.
Prenat Diagn ; 36(12): 1091-1098, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27739584

RESUMEN

OBJECTIVE: To evaluate preferences and decision-making among high-risk pregnant women offered a choice between Non-Invasive Prenatal Testing (NIPT), invasive testing or no further testing. METHODS: Nationwide implementation study (TRIDENT) offering NIPT as contingent screening test for women at increased risk for fetal aneuploidy based on first-trimester combined testing (>1:200) or medical history. A questionnaire was completed after counseling assessing knowledge, attitudes and participation following the Multidimensional Measure of Informed Choice. RESULTS: A total of 1091/1253 (87%) women completed the questionnaire. Of these, 1053 (96.5%) underwent NIPT, 37 (3.4%) invasive testing and 1 (0.1%) declined testing. 91.7% preferred NIPT because of test safety. Overall, 77.9% made an informed choice, 89.8% had sufficient knowledge and 90.5% had positive attitudes towards NIPT. Women with intermediate (odds ratio (OR) = 3.51[1.70-7.22], p < 0.001) or high educational level (OR = 4.36[2.22-8.54], p < 0.001) and women with adequate health literacy (OR = 2.60[1.36-4.95], p = 0.004) were more likely to make an informed choice. Informed choice was associated with less decisional conflict and less anxiety (p < 0.001). Intention to terminate the pregnancy for Down syndrome was higher among women undergoing invasive testing (86.5%) compared to those undergoing NIPT (58.4%) (p < 0.001). CONCLUSIONS: The majority of women had sufficient knowledge and made an informed choice. Continuous attention for counseling is required, especially for low-educated and less health-literate women. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.


Asunto(s)
Ansiedad/psicología , Actitud Frente a la Salud , Trastornos de los Cromosomas/diagnóstico , Conflicto Psicológico , ADN/sangre , Toma de Decisiones , Alfabetización en Salud , Análisis de Secuencia de ADN/métodos , Adulto , Cromosomas Humanos Par 13 , Cromosomas Humanos Par 18 , Síndrome de Down/diagnóstico , Escolaridad , Reacciones Falso Positivas , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Países Bajos , Embarazo , Primer Trimestre del Embarazo , Encuestas y Cuestionarios , Factores de Tiempo , Trisomía/diagnóstico , Síndrome de la Trisomía 13 , Síndrome de la Trisomía 18 , Adulto Joven
5.
Prenat Diagn ; 35(6): 549-57, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25644120

RESUMEN

OBJECTIVE: This study evaluates pregnant women's and healthcare professionals' preferences regarding specific prenatal screening and diagnostic test characteristics. METHOD: A discrete choice experiment was developed to assess preferences for prenatal tests that differed in seven attributes: minimal gestational age, time to test results, level of information, detection rate, false positive rate, miscarriage risk and costs. RESULTS: The questionnaire was completed by 596 (70.2%) pregnant women and 297 (51.7%) healthcare professionals, of whom 507 (85.1%) and 283 (95.3%), respectively, were included in further analyses as their choice behavior indicated prenatal testing was an option to them. Comparison of results showed differences in relative importance attached to attributes, further reflected by differences in willingness to trade between attributes. Pregnant women are willing to accept a less accurate test to obtain more information on fetal chromosomal status or to exclude the risk of procedure-related miscarriage. Healthcare professionals consider level of information and miscarriage risk to be most important as well but put more emphasis on timing and accuracy. CONCLUSION: Pregnant women and healthcare professionals differ significantly in their preferences regarding prenatal test characteristics. Healthcare professionals should take these differences into consideration when counseling pregnant women on prenatal testing.


Asunto(s)
Actitud del Personal de Salud , Conducta de Elección , Partería , Obstetricia , Prioridad del Paciente , Diagnóstico Prenatal/métodos , Aborto Espontáneo/etiología , Adolescente , Adulto , Reacciones Falso Positivas , Femenino , Edad Gestacional , Costos de la Atención en Salud , Humanos , Masculino , Persona de Mediana Edad , Embarazo , Diagnóstico Prenatal/efectos adversos , Diagnóstico Prenatal/economía , Sensibilidad y Especificidad , Encuestas y Cuestionarios , Factores de Tiempo , Adulto Joven
6.
Eur J Hum Genet ; 24(10): 1409-16, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27189020

RESUMEN

Early in pregnancy women and their partners face the complex decision on whether or not to participate in prenatal testing for fetal chromosomal abnormalities. Several studies show that the majority of pregnant women currently do not make informed decisions regarding prenatal testing. As the range of prenatal tests is expanding due to the development of new techniques such as non-invasive prenatal testing (NIPT), autonomous reproductive decision-making is increasingly challenging. In this study, a randomised controlled trial was conducted to evaluate the effect of a web-based multimedia decision aid on decision-making regarding prenatal testing. The decision aid provided both written and audiovisual information on prenatal tests currently available, that is, prenatal screening by first-trimester combined testing, NIPT and invasive diagnostic testing through chorionic villus sampling or amniocentesis. Furthermore, it contained values clarification exercises encouraging pregnant women to reflect on the potential harms and benefits of having prenatal tests performed. The use of the decision aid improved informed decision-making regarding prenatal testing. Of pregnant women allocated to the intervention group (n=130) 82.3% made an informed choice compared with 66.4% of women in the control group (n=131), P=0.004. As the vast majority of pregnant women made decisions consistent with their attitudes towards having prenatal testing performed, this improvement in informed decision-making could be attributed mainly to an increase in decision-relevant knowledge. This study shows that the implementation of a web-based multimedia decision aid directly facilitates the ultimate goal of prenatal testing for fetal chromosomal abnormalities, which is enabling informed autonomous reproductive choice.


Asunto(s)
Consentimiento Informado , Educación del Paciente como Asunto , Diagnóstico Prenatal/psicología , Adulto , Toma de Decisiones , Femenino , Humanos , Internet , Embarazo
7.
Expert Rev Mol Diagn ; 15(1): 111-24, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25347354

RESUMEN

Noninvasive prenatal testing (NIPT) for fetal aneuploidies using cell-free fetal DNA in maternal plasma has revolutionized the field of prenatal care and methods using massively parallel sequencing are now being implemented almost worldwide. Substantial progress has been made from initially testing for (an)euploidies of chromosomes 13, 18 and 21, to testing for sex chromosome (an)euploidies, additional autosomal aneuploidies as well as partial deletions and duplications genome-wide. Although NIPT is associated with significantly reduced risks for the fetus in comparison to existing invasive prenatal diagnostic methods, it presents several implementation challenges. Here, we review key issues potentially influencing NIPT and illustrate them using both data from literature and in-house data.


Asunto(s)
Secuenciación de Nucleótidos de Alto Rendimiento/normas , Diagnóstico Prenatal/normas , Aberraciones Cromosómicas , Mapeo Cromosómico , Análisis Mutacional de ADN , Femenino , Pruebas Genéticas , Humanos , Técnicas de Diagnóstico Molecular , Polimorfismo de Nucleótido Simple , Embarazo , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
8.
Eur J Obstet Gynecol Reprod Biol ; 182: 53-61, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25238658

RESUMEN

OBJECTIVE: Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma has been developed for the detection of fetal aneuploidy. Clinical trials have shown high sensitivity and specificity for trisomy 21 (T21) in both high-risk and average-risk populations. Although its great potential for prenatal medicine is evident, more information regarding the consequences of implementing NIPT in a national programme for prenatal screening is required. STUDY DESIGN: A decision-analytic model was developed to compare costs and outcomes of current clinical practice in The Netherlands using conventional screening only, with two alternatives: implementing NIPT as an optional secondary screening test for those pregnancies complicated by a high risk for T21, and implementing NIPT as primary screening test, replacing conventional screening. Probability estimates were derived from a systematic review of international literature. Costs were determined from a health-care perspective. Data were analysed to obtain outcomes, total costs, relative costs and incremental cost-effectiveness ratios (ICERs) for the different strategies. Sensitivity analysis was used to assess the impact of assumptions on model results. RESULTS: Implementing NIPT as an optional secondary, or as primary screening test will increase T21 detection rate by 36% (from 46.8% to 63.5%) and 54% (from 46.8% to 72.0%), simultaneously decreasing the average risk of procedure-related miscarriage by 44% (from 0.0168% to 0.0094% per pregnant woman) and 62% (from 0.0168% to 0.0064% per pregnant woman), respectively. None of the strategies clearly dominated: current clinical practice is the least costly, whereas implementing NIPT will cause total costs of the programme to increase by 21% (from €257.09 to €311.74 per pregnant woman), leading to an ICER of k€94 per detected case of T21, when utilised as an optional secondary screening test and by 157% (from €257.09 to €660.94 per pregnant woman), leading to an ICER of k€460 per detected case of T21, when utilised as primary screening test. However, implementing NIPT as triage test did result in the lowest expected relative costs per case of T21 diagnosed (k€141). CONCLUSION: NIPT should be implemented in national health care as an optional secondary screening test for those pregnancies complicated by a high risk for T21.


Asunto(s)
ADN/sangre , Síndrome de Down/diagnóstico , Pruebas Genéticas/economía , Política de Salud/economía , Diagnóstico Prenatal/economía , Aborto Espontáneo/etiología , Adulto , Amniocentesis/efectos adversos , Amniocentesis/economía , Aneuploidia , Muestra de la Vellosidad Coriónica/efectos adversos , Muestra de la Vellosidad Coriónica/economía , Análisis Costo-Beneficio , Árboles de Decisión , Femenino , Humanos , Países Bajos , Embarazo , Diagnóstico Prenatal/efectos adversos , Diagnóstico Prenatal/métodos , Factores de Riesgo , Ultrasonografía Prenatal
9.
Clin Biochem ; 46(18): 1783-6, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23933476

RESUMEN

OBJECTIVES: Circulating cell-free fetal DNA (ccffDNA) in maternal plasma is an attractive source for noninvasive prenatal testing (NIPT). The amount of total cell-free DNA significantly increases 24h after venipuncture, leading to a relative decrease of the ccffDNA fraction in the blood sample. In this study, we evaluated the downstream effects of extended processing times on the reliability of aneuploidy detection by massively parallel sequencing (MPS). DESIGN AND METHODS: Whole blood from pregnant women carrying normal and trisomy 21 (T21) fetuses was collected in regular EDTA anti-coagulated tubes and processed within 6h, 24 and 48h after venipuncture. Samples of all three different time points were further analyzed by MPS using Z-score calculation and the percentage of ccffDNA based on X-chromosome reads. RESULTS: Both T21 samples were correctly identified as such at all time-points. However, after 48h, a higher deviation in Z-scores was noticed. Even though the percentage of ccffDNA in a plasma sample has been shown previously to significantly decrease 24h after venipuncture, the percentages based on MPS results did not show a significant decrease after 6, 24 or 48h. CONCLUSIONS: The quality and quantity of ccffDNA extracted from plasma samples processed up to 24h after venipuncture are sufficiently high for reliable downstream NIPT analysis by MPS. Furthermore, we show that it is important to determine the percentage of ccffDNA in the fraction of the sample that is actually used for NIPT, as downstream procedures might influence the fetal or maternal fraction.


Asunto(s)
ADN/sangre , Pruebas Genéticas/métodos , Diagnóstico Prenatal/métodos , Aneuploidia , Síndrome de Down/diagnóstico , Síndrome de Down/genética , Femenino , Edad Gestacional , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Masculino , Flebotomía , Embarazo , Reproducibilidad de los Resultados , Factores de Tiempo
10.
IEEE Trans Biomed Eng ; 57(3): 519-27, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19884073

RESUMEN

The surface electrohysterographic (EHG) signal represents the bioelectrical activity that triggers the mechanical contraction of the uterine muscle. Previous work demonstrated the relevance of the EHG signal analysis for fetal and maternal monitoring as well as for prognosis of preterm labor. However, for the introduction in the clinical practice of diagnostic and prognostic EHG techniques, further insights are needed on the properties of the uterine electrical activation and its propagation through biological tissues. An important contribution for studying these phenomena in humans can be provided by mathematical modeling. A five-parameter analytical model of the EHG volume conductor and the cellular action potential (AP) is proposed here and tested on EHG signals recorded by a grid of 64 high-density electrodes. The model parameters are identified by a least-squares optimization method that uses a subset of electrodes. The parameters representing fat and abdominal muscle thickness are also measured by echography. The mean correlation coefficient and standard deviation of the difference between the echographic and EHG estimates were 0.94 and 1.9 mm, respectively. No bias was present. These results suggest that the model provides an accurate description of the EHG AP and the volume conductor, with promising perspectives for future applications.


Asunto(s)
Electrodiagnóstico/métodos , Monitoreo Fetal/métodos , Modelos Biológicos , Procesamiento de Señales Asistido por Computador , Contracción Uterina/fisiología , Potenciales de Acción/fisiología , Algoritmos , Simulación por Computador , Electrodiagnóstico/instrumentación , Femenino , Monitoreo Fetal/instrumentación , Humanos , Análisis de los Mínimos Cuadrados , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA